इसराइल - हिब्रू - Ministry of Health

taro pharmaceutical industries ltd - oxcarbazepine 600 mg - film coated tablets - carboxamide derivatives - treatment of primary generalised tonic - clonic seizures and partial seizures with or without secondary generalization.

इसराइल - हिब्रू - Ministry of Health

glaxo smith kline (israel) ltd - live attenuated measles virus; live attenuated mumps virus; live attenuated rubella virus; live attenuated varicella virus - אבקה וממס להכנת תמיסה להזרקה - live attenuated measles virus 10^ 3.0 ccid50; live attenuated mumps virus 10^ 4.4 ccid50; live attenuated rubella virus 10^ 3.0 ccid50; live attenuated varicella virus 10^ 3.3 pfu - measles, combinations with mumps, rubella and varicella, live attenuated - measles, combinations with mumps, rubella and varicella, live attenuated - priorix-tetra is indicated for active immunisation against measles, mumps, rubella and varicella in children from the age of 12 months up and including 12 years of age.

इसराइल - हिब्रू - Ministry of Health

abic marketing ltd - risedronic acid sodium 75 mg - tablets - risedronic acid - treatment of osteoporosis in postmenopausal women at increased risk of fractures.prevention of osteoporosis in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of fracture.

इसराइल - हिब्रू - Ministry of Health

glaxo smith kline (israel) ltd - varicella zoster virus glycoprotein e antigen - אבקה ותרחיף להכנת תרחיף להזרקה - varicella zoster virus glycoprotein e antigen 50 mcg - zoster, purified antigen

इसराइल - हिब्रू - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

इसराइल - हिब्रू - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

इसराइल - हिब्रू - Ministry of Health

cts ltd - tamsulosin hydrochloride - film coated tablets - tamsulosin hydrochloride 0.4 mg - tamsulosin - tamsulosin - lower urinary tract symptoms ( luts) associated with benign prostatic hyperplasia (bph).

इसराइल - हिब्रू - Ministry of Health

dexcel pharma technologies ltd - clopidogrel as besylate 75 mg - film coated tablets - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows:• recent mi, recent stroke or established peripheral arterial disease: patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. for patients with a history of recent myocardial infarction (mi), recent stroke or established peripheral arterial disease, clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new mi (fatal or not) and other vascular death.• acute coronary syndrome: for patients with acute coronary syndrome (non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction), in combination with asa in medically treated patients eligible for thrombolytic therapy, and those who are to be managed with percutaneous coronary intervention (with or without stent) or cabg clopi

इसराइल - हिब्रू - Ministry of Health

novartis pharma services ag - aliskiren 150 mg - film coated tablets - aliskiren - treatment of essential hypertension.

इसराइल - हिब्रू - Ministry of Health

novartis pharma services ag - aliskiren 300 mg - film coated tablets - aliskiren - treatment of essential hypertension.